Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Flomax (tamsulosin) Treatment Report
What is Flomax?

Flomax® (tamsulosin) is used to manage the signs and symptoms of benign prostatic hyperplasia (BPH). It relaxes the smooth muscle in the bladder neck and prostate causing an improvement of urine flow. Off label it is used for symptomatic treatment of bladder outlet obstruction or dysfunction.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 7 1
Urinary urgency 7 0
General health 3 1
swollen prostate 3 0
Insomnia 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 50%
Moderate
0 0%
Mild
0 0%
None
1 50%

Most commonly reported side effects

pain in testies
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 0.04 mg daily 0.4 mg daily 0.8 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 15 Number of Patients: 15 4 Number of Patients: 4  

Stop Reasons

Why Patients Stopped Taking Flomax (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 50% Side effects too severe: 50%
Other
2 50% Other: 50%
Did not seem to work
1 25% Did not seem to work: 25%

See all 4 patients who’ve stopped taking Flomax

Currently Taking Flomax

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
1
2
7

Stopped Taking Flomax

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
3
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.